A phase 2 randomised study of veliparib plus FOLFIRIÂbevacizumab versus placebo plus FOLFIRIÂbevacizumab in metastatic colorectal cancer

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

18:22 EST 10 Dec 2018 | Nature Publishing

More From BioPortfolio on "A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer"